Universitätsklinikum Hamburg-Eppendorf (UKE)

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025) Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, et al. Journal article Tackling gender in progressive supranuclear palsy: Male patients present more apathy (2025) Ye L, Greten S, Wilkens I, Wegner F, Krey L, Höllerhage M, Pötter-Nerger M, et al. Journal article Machine Learning Classification of Smoking Behaviours—From Social Environment to the Prefrontal Cortex (2025) Reinhardt P, Zacharias N, Fislage M, Böhmer J, Hollunder B, Reppmann Z, Wiehe A, et al. Journal article Colorectal Carcinoma in Childhood and Adolescence: Microsatellite Instability Correlates With a Favorable Prognosis (2025) Wild H, Liebmann A, Maennel L, Maschke L, Block A, Kager L, Kontny U, et al. Journal article Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma. (2025) DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, et al. Journal article Digital empowerment on hold: DiGA adoption gaps−a German national cross-sectional patient survey study (2025) Kremer P, Fink D, Morf H, Labinsky H, Gente K, Aries P, Krusche M, et al. Journal article Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment Recommendations (2025) Untch M, Banys-Paluchowski M, Brucker SY, Denkert C, Fasching P, Haidinger R, Harbeck N, et al. Journal article, Review article Loss of genome maintenance is linked to mTOR complex 1 signaling and accelerates podocyte damage (2025) Braun F, Mandel AM, Blomberg L, Wong MN, Chatzinikolaou G, Meyer DH, Reinelt A, et al. Journal article Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland (2025) Seidel D, Pana ZD, Ebrahimi-Fakhari D, Butzer SK, Mehler K, Reinhold I, Simon A, et al. Journal article Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025) Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching P, Harbeck N, et al. Journal article